N-(3-Methoxyimino-5beta-cholan-24-oyl)-L-beta-homo-tryptophan

ID: ALA4090681

PubChem CID: 137643073

Max Phase: Preclinical

Molecular Formula: C37H53N3O4

Molecular Weight: 603.85

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CO/N=C1\CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)N[C@H](CC(=O)O)Cc4c[nH]c5ccccc45)CC[C@@H]32)C1

Standard InChI:  InChI=1S/C37H53N3O4/c1-23(9-14-34(41)39-27(21-35(42)43)19-24-22-38-33-8-6-5-7-28(24)33)30-12-13-31-29-11-10-25-20-26(40-44-4)15-17-36(25,2)32(29)16-18-37(30,31)3/h5-8,22-23,25,27,29-32,38H,9-21H2,1-4H3,(H,39,41)(H,42,43)/b40-26+/t23-,25-,27+,29+,30-,31+,32+,36+,37-/m1/s1

Standard InChI Key:  ICXZJAYZTYLYEN-NXBMQGHCSA-N

Molfile:  

     RDKit          2D

 49 54  0  0  0  0  0  0  0  0999 V2000
    3.5040  -18.5106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5040  -19.3278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2093  -19.7323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2093  -18.0979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9146  -18.5106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9156  -19.3278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6199  -19.7332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3277  -19.3260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6178  -18.0989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3286  -18.5095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3274  -16.8707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6141  -17.2803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0381  -17.2813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0350  -18.1029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8155  -18.3598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3010  -17.6969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8205  -17.0304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9073  -17.6934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9114  -20.1409    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.6130  -18.9151    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    6.3229  -17.6893    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    7.0287  -18.9192    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    7.0328  -16.4635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0759  -16.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8759  -16.0873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5314  -15.6448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4204  -16.6966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2204  -16.5297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4758  -15.7535    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6053  -16.8143    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   10.7649  -17.1390    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5649  -16.9721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8203  -16.1959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6203  -16.0290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8757  -15.2527    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1648  -16.6383    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.1094  -17.5815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8540  -18.3577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0764  -18.6069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0733  -19.4241    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3323  -19.0202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8489  -19.6756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1750  -20.4199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9842  -20.5099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4663  -19.8496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1375  -19.1079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7969  -19.7374    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0886  -19.3299    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3815  -19.7395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  5  9  1  0
  6  7  1  0
  7  8  1  0
  8 10  1  0
  9 10  1  0
  9 12  1  0
 10 14  1  0
 13 11  1  0
 11 12  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
  5 18  1  1
  6 19  1  1
  9 20  1  6
 10 21  1  1
 14 22  1  6
 13 23  1  1
 17 24  1  0
 24 25  1  0
 24 26  1  6
 25 27  1  0
 27 28  1  0
 28 29  2  0
 17 30  1  6
 28 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 32 37  1  6
 37 38  1  0
 38 39  2  0
 39 40  1  0
 40 42  1  0
 41 38  1  0
 41 42  2  0
 42 43  1  0
 43 44  2  0
 44 45  1  0
 45 46  2  0
 46 41  1  0
  2 47  2  0
 47 48  1  0
 48 49  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4090681

    ---

Associated Targets(non-human)

Epha2 Ephrin type-A receptor 2 (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 603.85Molecular Weight (Monoisotopic): 603.4036AlogP: 7.75#Rotatable Bonds: 10
Polar Surface Area: 103.78Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.62CX Basic pKa: 3.59CX LogP: 6.66CX LogD: 4.17
Aromatic Rings: 2Heavy Atoms: 44QED Weighted: 0.24Np Likeness Score: 1.07

References

1. Incerti M, Russo S, Callegari D, Pala D, Giorgio C, Zanotti I, Barocelli E, Vicini P, Vacondio F, Rivara S, Castelli R, Tognolini M, Lodola A..  (2017)  Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.,  60  (2): [PMID:28005388] [10.1021/acs.jmedchem.6b01642]

Source